Within-person pain variability and physical activity in older adults with osteoarthritis from six European countries by Timmermans, Erik J. et al.
RESEARCH ARTICLE Open Access
Within-person pain variability and physical
activity in older adults with osteoarthritis
from six European countries
Erik J. Timmermans1* , Elisa J. de Koning1, Natasja M. van Schoor1, Suzan van der Pas1, Michael D. Denkinger2,
Elaine M. Dennison3, Stefania Maggi4, Nancy L. Pedersen5, Ángel Otero6, Richard Peter7, Cyrus Cooper3,
Paola Siviero4, Maria Victoria Castell6, Florian Herbolsheimer7, Mark Edwards3, Federica Limongi4,
Dorly J. H. Deeg1 and Laura A. Schaap8
Abstract
Background: This study examines the association of both pain severity and within-person pain variability with
physical activity (PA) in older adults with osteoarthritis (OA).
Methods: Data from the European Project on OSteoArthritis were used. At baseline, clinical classification criteria of
the American College of Rheumatology were used to diagnose OA in older adults (65–85 years). At baseline and
12–18 months follow-up, frequency and duration of participation in the activities walking, cycling, gardening, light
and heavy household tasks, and sports activities were assessed with the Longitudinal Aging Study Amsterdam
Physical Activity Questionnaire. Physical activity was calculated in kcal/day, based on frequency, duration, body
weight and the metabolic equivalent of each activity performed. At baseline and 12–18 months follow-up, pain
severity was assessed using the pain subscales of the Western Ontario and McMaster Universities OA Index and the
Australian/Canadian Hand OA Index. Within-person pain variability was assessed using two-week pain calendars that
were completed at baseline, 6 months follow-up and 12–18 months follow-up.
Results: Of all 669 participants, 70.0% were women. Sex-stratified multiple linear regression analyses showed that
greater pain severity at baseline was cross-sectionally associated with less PA in women (Ratio = 0.95, 95% CI = 0.90–0.
99), but not in men (Ratio = 0.99, 95% CI = 0.85–1.15). The longitudinal analyses showed a statistically significant inverse
association between pain severity at baseline and PA at follow-up in women (Ratio = 0.94, 95% CI = 0.89–0.99), but not
in men (Ratio = 1.00, 95% CI = 0.87–1.11). Greater pain variability over 12–18months was associated with more PA at
follow-up in men (Ratio = 1.18, 95% CI = 1.01–1.38), but not in women (Ratio = 0.94, 95% CI = 0.86–1.03).
Conclusions: Greater pain severity and less pain variability are associated with less PA in older adults with OA. These
associations are different for men and women. The observed sex differences in the various associations should be
studied in more detail and need replication in future research.
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Background
Osteoarthritis (OA) is one of the most common muscu-
loskeletal disorders worldwide [1]. The condition is a
leading cause of disability and a major contributor to
loss of independence among older adults, with joint pain
representing one of the key debilitating symptoms [1–3].
While OA is characterized as a slowly progressive dis-
ease, acute flares, episodes of severe pain, and substantial
fluctuations in pain intensity are part of the natural
course of the condition [4, 5]. It has been suggested that
physical activity (PA) reduces joint pain in older adults
with OA, and helps them to maintain or improve func-
tioning [6–10]. Despite the potential health benefits of
PA are well established, the majority of older people with
OA are not sufficiently physically active [11–16]. Besides
the fear of continuing or worsening wear and tear within
the joint, it has been suggested that the most important
reason for older adults with OA to avoid physical activ-
ities is pain that is associated with initiating activities
[15, 17–19].
Pain patterns differ substantially across individuals
with OA [4, 5, 20, 21]. Several studies have shown that
higher levels of pain severity are associated with less PA
in older people with OA [15, 18, 19, 22, 23]. Although
joint pain often fluctuates in older adults with OA, pre-
vious studies mainly focused on the impact of moment-
ary joint pain severity on PA and did not investigate the
association between joint pain variability and PA in these
individuals.
The fluctuating course of joint pain in OA requires re-
peated measurements and is difficult to capture in re-
search based on commonly used extensive instruments,
such as the Western Ontario and McMaster Universities
OA Index (WOMAC) and the Australian/Canadian Hand
Osteoarthritis Index (AUSCAN) [24–26]. Pain variability
can more easily be measured using pain calendars (i.e.,
pain diaries) over a large period of time. In the European
Project on OSteoArthritis (EPOSA), WOMAC, AUSCAN
as well as pain calendars have been used to assess pain
[27]. The EPOSA study provides a unique opportunity to
assess the association of both pain severity and
within-person pain variability with PA in older adults with
OA in the general population across six European coun-
tries, including both older adults with mild and severe
OA, and those seeking care and not seeking care [27]. As-
suming that a lack of predictability of pain is detrimental
to PA [18], it is hypothesized that greater pain severity and
greater pain variability over time is associated with less PA
in these individuals.
Methods
Design and study sample
In the present study, data from the European Project on
OSteoArthritis (EPOSA) were used. The main objective
of the EPOSA study is to investigate the personal and
societal burden of OA and its determinants in older
adults in six European countries. The study design and
data collection are described in detail elsewhere [27]. In
summary, random samples were taken from existing
population-based cohorts in five European countries
(Germany, the Netherlands, Spain, Sweden, and the
United Kingdom). In Italy, a new sample was drawn. In
the EPOSA study, the data collection took place twice
with 12–18months between the baseline and the
follow-up measurement. At baseline and 12–18months
follow-up, a total of 2942 (average response rate: 72.8%
(range: 64.6–82.2%)) and 2455 (average response rate:
83.4% (range: 68.2–92.3%)) older adults, respectively,
participated in the EPOSA project. All participants were
interviewed by a trained interviewer at home or in a
clinical center, using a standardized questionnaire and a
clinical exam. After the baseline and 12–18months
follow-up interview as well as 6 months after the base-
line interview, participants were asked to complete a
two-week calendar assessing joint pain. At baseline, the
classification criteria of the American College of
Rheumatology were used to diagnose clinical knee, hand
and hip OA [28]. In total, 889 participants had knee,
hand and/or hip OA at baseline. Of all participants with
OA at baseline, 713 individuals also participated at
follow-up. The final analytical sample consisted of 669
older adults with clinical OA who participated at base-
line as well as at follow-up and did not report joint re-
placements at the site of the clinical OA. The study
design and all procedures were approved by the Ethical
Review Boards of the participating institutions. All par-
ticipants provided written informed consent prior to the
start of the study.
Measurements
Dependent variable
Physical activity At baseline and 12–18months
follow-up, physical activity (PA) was assessed using the
Longitudinal Aging Study Amsterdam Physical Activity
Questionnaire (LAPAQ) [29]. The LAPAQ examines the
frequency and duration of participation in different ac-
tivities (i.e., walking outside, cycling, gardening, light
and heavy household tasks, and a maximum of two
sports) during the previous two weeks. Physical activity
was calculated in kcal/day, based on frequency, duration,
body weight and the metabolic equivalent of each per-
formed activity.
Independent variables
Pain severity At baseline and 12–18 months follow-up,
pain severity in the past 48 h was measured with the
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WOMAC (knee and hip OA) and the AUSCAN (hand
OA) pain subscales. The WOMAC and AUSCAN pain
subscales are described in detail elsewhere [24, 25]. Be-
cause these pain subscales are scored on the same scale
(score range: 0–20), the scores of knee, hip and hand
pain were added up, resulting in a total joint pain sever-
ity score (score range: 0–60). For comparability to other
studies [24–26], this WOMAC/AUSCAN combined pain
score was transformed to a 0–100 scale. A higher
WOMAC/AUSCAN combined pain score indicates
more joint pain.
Pain variability Pain variability was assessed with two
-week pain calendars completed by participants immedi-
ately after the baseline interview, six months later and
after the 12–18months follow-up interview. Participants
from Spain did not complete the pain calendar at
6-months follow-up. Per day, participants indicated how
much joint pain they experienced on an 11-point rating
scale (score range: 0–10). On this rating scale, a score of 0
represents no pain and a score of 10 indicates extreme
pain. For each participant, the standard deviation (SD) of
the scores from all available days of the three calendars
was used as measure of individual day-to-day pain vari-
ability. A larger individual SD score indicates more
day-to-day pain variability within a person. At least 7 of
14 days of at least one calendar had to be completed by a
participant in order to be included in the pain variability
analyses. This approach corresponds with previous re-
search [26].
Potential effect modifiers and confounders Age, sex
(0 =men, 1 = women), and country of residence were
considered as potential effect modifiers in the associ-
ation between pain and PA [30–32]. Age was categorized
into younger-old people and older-old people on the
basis of 1–2 quartiles (65.0–74.0 years) and 3–4 quartiles
(74.1–85.0 years), respectively. Country of residence was
dummy-coded and included: Germany, Italy, the
Netherlands, Spain, Sweden, and the United Kingdom.
Sweden was considered as the reference category, be-
cause the Swedish respondents reported, on average, to
be physically less active.
The following potential confounders were considered
in this study: age in years, sex, country of residence (if
no effect modifiers), educational level, smoking, alcohol
consumption, weight status, number of chronic diseases,
and use of pain medications.
Educational level was classified into four categories: no
education (reference category; elementary school not
completed), low (elementary school completed), inter-
mediate (vocational or general secondary education),
and high (college or university education).
Smoking status was self-reported and classified into
three categories: never smokers (reference category),
former smokers, and current smokers. Alcohol con-
sumption was self-reported (0 = no, 1 = yes).
Weight status was assessed using the Body Mass
Index, which was calculated as weight in kilograms di-
vided by height in meters squared [33]. The weight of
participants was measured to the nearest 0.1 kg using a
calibrated scale. The height of participants was measured
to the nearest 0.001 m using a stadiometer.
Number of chronic diseases was assessed by asking for
the presence of the following chronic diseases: chronic
non-specific lung disease, cardiovascular diseases, per-
ipheral artery diseases, diabetes mellitus, stroke, cancer,
and osteoporosis.
Medication use (0 = no, 1 = yes) referred to the use of
analgesics (Anatomical Therapeutic Chemical classifica-
tion: N02 subgroup) and/or anti-inflammatory and
anti-rheumatic products (Anatomical Therapeutic
Chemical classification: M01 subgroup).
Statistical analyses Characteristics of the study sample
were presented using descriptive statistics. Means and
SDs were presented for normally distributed continuous
variables. Medians and interquartile ranges (IQRs) were
presented for skewed continuous variables. Frequencies
and proportions were presented for dichotomous or cat-
egorical variables. With the exception of age, sex and
country, all descriptive statistics were weighted to adjust
for differences in the distributions of age and sex across
the samples of the six cohort studies. Weights were cal-
culated per sex and per five-year age category, using the
formula W=Nexp/Nobs, where Nexp is the number of per-
sons in a specific age/sex category in the European
population and Nobs is the number of persons in a spe-
cific age/sex category in the cohort [26, 34].
Multiple linear regression analyses were used to exam-
ine the associations between each pain measure and PA.
To study possible effect modification by age, sex, and
country of residence, an interaction term of the deter-
minant with the potential effect modifier was created.
This interaction term was added to the model. If the
p-value of the interaction term was below 0.10, effect
modification was considered to be present and stratified
analyses were conducted [35]. In case it turned out that
age, sex or country of residence was no effect modifier,
the variable was considered as confounder in the subse-
quent analyses.
The associations between the pain measures and PA
were constructed step by step in two models. In Model 1,
we adjusted for age, sex, and country of residence (if no
effect modifiers). In Model 2, we additionally adjusted for
educational level, smoking, alcohol consumption, weight
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status, number of chronic diseases, and use of
medications.
For pain severity, both cross-sectional and longitudinal
multiple linear regression analyses were conducted. For
the cross-sectional analysis, the baseline WOMAC/AUS-
CAN combined pain score was the main determinant
and PA at baseline the continuous outcome measure. To
examine the prospective association between pain sever-
ity and PA, the baseline WOMAC/AUSCAN combined
pain score was the main determinant and PA at
follow-up the outcome measure. In this analysis, PA at
baseline was used as additional covariate.
To study whether pain fluctuations over time affect
PA, multiple linear regression analyses were conducted
with the individual joint pain SDs (calculated from the
three two-week pain calendars at baseline, 6 months
follow-up and 12–18 months follow-up) as the main de-
terminant and PA at 12–18months follow-up as out-
come measure.
Three pre-planned sensitivity analyses were conducted.
A potential disadvantage of using the SD of the individ-
ual pain intensity scores from all available pain calendar
days as measure of day-to-day pain variability is that the
SD is the same for individuals who report the same ex-
tent of fluctuations, regardless of their mean pain inten-
sity score [26]. For example, two persons with mean
pain intensity levels of 0 and 10, respectively, who ex-
perience no pain fluctuations, will both have a SD of 0.
In the first pre-planned sensitivity analysis, we repeated
the pain variability analysis whilst leaving out persons
with no or only little reported joint pain (mean pain
score on at least one calendar ≤2).
Hip and knee OA might be more strongly related to
the physical activities that are assessed by the LAPAQ.
In the second pre-planned sensitivity analysis, we re-
peated all analyses whilst leaving out persons with only
hand OA. It is expected that these analyses reveal stron-
ger associations of both pain severity and within-person
pain variability with PA than those in which also partici-
pants with hand OA are included.
In the present study, the pain calendar at 12–18
months follow-up was completed in the two weeks after
the PA assessment. However, we defined PA as our
dependent variable. In the third pre-planned sensitivity
analysis, we repeated the pain variability analyses whilst
leaving out the 12–18months pain calendar.
Because the distribution of PA was skewed to the right,
we performed a natural log transformation on the LAPAQ
data (i.e., Ln(1 + LAPAQ score) in the present study. The
regression coefficients and confidence intervals (CIs) from
the multiple linear regression analyses were back-trans-
formed to obtain interpretable ratios. From these ratios, a
percentage of change in the outcome variable (PA) per
one-unit change in the determinant (pain) can be derived.
Because a one-unit change on the pain severity scale of 0–
100 is very small, we derived a more meaningful 10-unit
change in the present study [36]. A two-sided p-value
below 0.05 was considered as statistically significant. All
analyses were conducted with IBM SPSS Statistics for Win-
dows, Version 22.0 [37].
Results
The characteristics of the study sample are presented in
Table 1. The mean age of all 669 participants at baseline
was 73.9 (SD = 4.9) years with an age-range of 65–85
years. The majority (70.0%) of participants was woman.
Of all 669 participants, 62.9% had knee OA, 19.9% had
hip OA, and 56.5% had hand OA. At baseline and 12–
18months follow-up, the average pain severity was 18.1
(SD = 12.3) and 17.9 (SD = 15.0) on the WOMAC/AUS-
CAN combined pain score, respectively. The participants
completed, on average, 34.2 (SD = 9.2) (range = 7–42
days) days of the pain calendars. In the full sample, the
average pain variability on the pain calendars was 1.4
(SD = 0.8) individual standard deviation units. At base-
line and 12–18months follow-up, the participants spent
691.5 (IQR = 437.4–1043.4) and 664.0 (IQR = 417.5–
1077.3) kcal/day on PA, respectively (Table 1).
In all analyses, sex was found to be a significant effect
modifier and, therefore, all analyses were stratified for
sex. Age and country of residence were not found to be
a significant effect modifier in all analyses.
Cross-sectional analyses: pain severity and physical
activity
After adjustment for age and country of residence, the
cross-sectional baseline association between pain sever-
ity and PA was statistically significant in women (Ratio
= 0.94, 95% CI = 0.89–0.98) (Table 2; Model 1). After
additional adjustment for all other confounders, the as-
sociation between pain severity and PA remained statis-
tically significant in women (Ratio = 0.95, 95% CI = 0.90–
0.99). Accordingly, a 10-unit higher pain severity score is
associated with 5% less PA (Table 2; Model 2). No statis-
tically significant association was observed between pain
severity and PA in men (Table 2).
Longitudinal analyses: pain severity and physical activity
After adjustment for age, country of residence and PA at
baseline, the prospective association between pain sever-
ity at baseline and PA at 12–18months follow-up was
statistically significant in women (Ratio = 0.94, 95% CI =
0.89–0.99) (Table 3; Model 1). After additional adjust-
ment for all other confounders, this association
remained unchanged in women (Ratio = 0.94, 95% CI =
0.89–0.99) (Table 3; Model 1). Accordingly, a 10-unit
higher pain severity score at baseline is associated with
6% less PA at follow-up in women. The prospective
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association between pain severity at baseline and PA at
12–18months follow-up was not statistically significant
in men (Table 3).
Longitudinal analyses: pain variability and physical activity
A greater pain variability over 12–18 months was signifi-
cantly associated with more PA in men (Ratio = 1.18,
95% CI = 1.01–1.38), but with less PA in women
although not significant (Ratio = 0.94, 95% CI = 0.86–
1.03) (Table 4; Model 2). Accordingly, a 1-unit higher
pain variability score is associated with 18% more PA in
men, and with 6% less PA in women.
Sensitivity analysis
The various sensitivity analyses did not change any of
the conclusions (results not shown).
Table 1 Characteristics of the study samplea,b
Study sample (n = 669) Men (n = 211) Women (n = 458)
Age (in years) (Mean (SD)) 73.9 (4.9) 74.5 (5.1) 73.7 (4.8)
Country (%)
Germany 8.4 9.5 7.9
Italy 17.6 19.9 16.6
Netherlands 16.6 14.7 17.4
Spain 21.8 20.4 22.5
Sweden 20.6 16.1 22.7
United Kingdom 14.9 19.4 12.9
Educational level (%)
No education 14.4 12.0 15.3
Low 35.4 35.1 35.5
Intermediate 32.3 35.7 31.0
High 17.9 17.2 18.2
Smoking (%)
Never 52.4 29.6 61.2
Former 41.9 63.9 33.5
Current 5.7 6.5 5.3
Alcohol consumption (yes) (%) 70.5 86.1 64.5
Weight status (BMI in kg/m2) (Mean (SD)) 28.5 (5.0) 28.4 (3.9) 28.5 (5.4)
Number of chronic diseases (Median (IQR)) 1 (0–2) 1 (0–2) 1 (0–2)
Use of analgesic and/or anti-inflammatory and
anti-rheumatic products (yes) (%)
32.7 33.0 32.6
Presence of clinical osteoarthritis (%)
Knee osteoarthritis 62.9 67.8 61.0
Hand osteoarthritis 56.5 42.7 61.9
Hip osteoarthritis 19.9 19.3 20.2
Pain severity at baseline (Mean (SD)) c
Baseline 18.1 (12.3) 14.6 (9.8) 19.4 (12.9)
Follow-up 17.9 (15.0) 13.7 (13.4) 19.6 (14.4)
Pain variability (Mean (SD)) d 1.4 (0.8) 1.4 (0.9) 1.4 (0.8)
Physical activity (in kcal/day)
(Median (IQR))
Baseline 691.5 (437.4–1043.4) 636.6 (383.1–1090.1) 704.0 (447.7–1030.4)
Follow-up 664.0 (417.5–1077.3) 662.4 (348.0–1146.2) 667.1 (436.8–1059.1)
aAbbreviations: BMI Body Mass Index, IQR Interquartile range, n Number of participants, kcal Kilocalories, kg/m2 kilogram per square meter, OA Osteoarthritis, SD
Standard deviation
bWith exception of age and country, descriptive statistics are weighted
cA higher pain severity score indicates more pain
dPain variability is presented in individual standard deviation units. A higher pain variability score indicates more day-to-day pain fluctuations
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Discussion
This study examined whether pain severity and pain fluc-
tuations over time were associated with PA in older adults
with OA from the general European population. The re-
sults showed that greater pain severity was associated with
less PA in women, but not in men. Furthermore, the find-
ings showed that greater pain variability was associated
with more PA in men. Pain variability was not associated
with PA in women. The various sensitivity analyses did
not result in substantially different findings.
The findings of this study showed that greater pain se-
verity was associated with less PA in older women. The
observed difference in this association between men and
women could be possibly explained by differences in
coping strategies that are used by men and women [38].
Pain catastrophizing is a pain coping strategy referring
to the exacerbation of pain-related information [38, 39],
while self-efficacy refers to the belief of a person in his
or her ability to achieve goals [38, 40]. Previous studies
have shown that catastrophizing is associated with pain
and pain-related disability and that women use this cop-
ing strategy more often than men [38, 41]. Previous
studies have also shown that men more often demon-
strate higher levels of self-efficacy than women [38, 42].
Furthermore, the observed sex-differences in the associ-
ation between pain severity and PA could be explained
by socio-cultural beliefs or gender role expectations re-
garding how men and women should respond to pain. It
might be less accepted from men than from women
when they adjust their PA levels because of greater pain
severity [38, 43]. The influencing role of different coping
strategies in the association between pain and PA in
older men and women with OA should be addressed in
future research.
The results of the present study showed that greater
pain variability was associated with more PA in older
men. On forehand, we expected that greater pain vari-
ability would mean more unpredictability, which may
lead to fear of sudden increases in pain, that would lead
individuals to reduce their activities and activity levels
[18]. A possible explanation for the current finding
could be that older men with OA, in periods of less pain,
become considerably more physically active, until pain
increases again. As a result, more pain fluctuations could
lead to more PA.
Although the results of the present study suggest that
pain severity and pain variability affect PA levels of older
adults with OA, it could also be that PA affects pain [7,
9]. It has been suggested that physical activity (e.g., su-
pervised exercise therapy) could strengthen the muscles
around an affected joint, which helps to stabilize the
joint and to absorb most of the forces presented to the
joint, resulting in less pain [44]. Future research is
needed to consider the possibility of reversed causality,
by examining how PA at baseline influences pain at
follow-up and what the potential implications of this re-
lationship are for PA at follow-up.
The EPOSA-project is a large-scale study with a
pre-harmonized dataset including prospective cohort
data from older adults with clinical knee, hand and/or
hip OA from six European countries [27]. An important
strength of our study is that the assessment of clinical
OA was performed according to a uniform protocol in
all six countries. Another strength is that the study
Table 2 Cross-sectional associations between pain severity and
physical activity, stratified by sexa-d
Men Women
Ratio (95% CI) p-value Ratio (95% CI) p-value
Model 1 1.00 (0.86–1.16) 0.97 0.94 (0.89–0.98) 0.02
Model 2 0.99 (0.85–1.15) 0.87 0.95 (0.90–0.99) 0.04
aAbbreviation: CI Confidence Interval
bIn these analyses, the baseline WOMAC/AUSCAN combined pain score was
the main determinant and physical activity at baseline the outcome measure
cModel 1: adjusted for age and country of residence
Model 2: additionally adjusted for educational level, smoking, alcohol
consumption, weight status, number of chronic diseases, and use of analgesics
and/or anti-inflammatory and anti-rheumatic products
dThe cross-sectional associations are displayed per 10 units increase in
pain severity
Table 3 Longitudinal associations between pain severity and
physical activity, stratified by sexa-d
Men Women
Ratio (95% CI) p-value Ratio (95% CI) p-value
Model 1 0.99 (0.88–1.11) 0.86 0.94 (0.89–0.99) 0.03
Model 2 1.00 (0.87–1.11) 0.81 0.94 (0.89–0.99) 0.02
aAbbreviation: CI Confidence Interval
bIn these analyses, the baseline WOMAC/AUSCAN combined pain score was
the main determinant and physical activity at 12–18months follow-up the
outcome measure
cModel 1: adjusted for age, country of residence, and physical activity
at baseline
Model 2: additionally adjusted for educational level, smoking, alcohol
consumption, weight status, number of chronic diseases, and use of analgesics
and/or anti-inflammatory and anti-rheumatic products
dThe longitudinal associations are displayed per 10 units increase in
pain severity
Table 4 Longitudinal associations between pain variability and
physical activity, stratified by sexa-c
Men Women
Ratio (95% CI) p-value Ratio (95% CI) p-value
Model 1 1.15 (0.98–1.33) 0.08 0.93 (0.85–1.02) 0.14
Model 2 1.18 (1.01–1.38) 0.04 0.94 (0.86–1.03) 0.21
aAbbreviation: CI Confidence Interval
bIn these analyses, the individual joint pain standard deviation score
(calculated from the three two-week pain calendars at baseline, 6 months
follow-up and 12–18 months follow-up) was the main determinant and
physical activity at 12–18 months follow-up the outcome measure
cModel 1: adjusted for age and country of residence
Model 2: additionally adjusted for educational level, smoking, alcohol
consumption, weight status, number of chronic diseases, and use of analgesics
and/or anti-inflammatory and anti-rheumatic products
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sample was drawn from the general population. Conse-
quently, our study includes data from individuals with
mild and severe OA. In addition, our study includes data
from persons seeking care and not seeking care. This in-
creases generalizability of our results. Furthermore, a
strength of this study is the assessment of day-to-day
pain variability using several two-week pain calendars
over a large time period. This is a novel and promising
way of investigating joint pain in OA [26].
The current study has some limitations as well. Firstly,
the participants in our study were not asked about other
types of pain that they may have experienced at the same
time as their joint pain. As a consequence, we were unable
to control for this potentially important confounder. Sec-
ondly, there was no exact overlap between the timing of
the pain assessments and the timing of the PA assess-
ments. In the present study, the pain calendar at 12–18
months follow-up was completed in the two weeks after
the PA assessment, whereas PA was our dependent vari-
able. However, the pain calendar started the day after the
12–18months follow-up interview, and consequently, the
time period between these assessments was quite short.
Excluding data from the third pain calendar would not
only reduce the statistical power of our analyses, but
would also mean that PA would be assessed six months
after the last pain calendar (and 12–18months for Spain),
which is a much longer period. The sensitivity analyses in
which the 12–18months pain calendar was left out
showed similar results as the main analyses. Thirdly, the
SD of the individual pain scores from all available days of
three two-week pain calendars was used as measure of
within-person pain variability in this study. It has been
suggested that these SD scores may suffer from relatively
low reliability [45], and this might be more pronounced if
the number of observations is low. In the current study,
we combined three two-week pain calendars in order to
make the reliability of the pain variability measure as high
as possible. For the majority of the participants, the indi-
vidual SD was calculated from 42 observations. Finally, PA
was self-reported using the LAPAQ [29]. It has been sug-
gested that self-reported PA has some limitations com-
pared to objectively measured PA, such as susceptibility to
overestimation, recall, and culture difference bias, espe-
cially in older adults [46, 47].
Overall, the current study may help to better under-
stand pain patterns in older adults with OA and how
these patterns affect daily functioning of these individ-
uals in terms of PA. However, the observed sex differ-
ences in the various associations should be studied in
more detail and need replication in future research. Ul-
timately, health care professionals could use the insights
gained from such studies in clinical encounters to tailor
recommendations for the timing of pain medication use
and PA behavioral strategies.
To obtain more detailed knowledge about the associ-
ation between OA-related pain and PA, future research
could objectively assess PA using accelerometers and let
participants fill in a pain calendar at the same time. Fur-
thermore, these studies could focus on whether pain
variability is associated with specific activities in men
and women, and whether there are differences in other
factors that may cause sex differences in the various
associations.
Conclusions
In conclusion, the present study showed that greater pain
severity was associated with less PA in older women.
Furthermore, the findings of this study show that greater
pain variability was associated with more PA in older men.
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